Day: March 8, 2022

Firm Capital Property Trust Announces Acquisition of $37 Million Edmonton Industrial Portfolio

Written by Customer Service on March 8, 2022. Posted in Mergers And Acquisitions.

TORONTO, March 08, 2022 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust”) (TSXV: FCD.UN) is pleased to announce the acquisition of a 50% interest in six multi-tenant industrial properties located in Edmonton, Alberta (the “Edmonton Industrial Portfolio” or the “Property”). The acquisition price for 100% of the Property is approximately $36.5 million, excluding transaction costs. The Edmonton Industrial Portfolio’s location offers excellent access to major vehicular and rail transportation infrastructure. The Edmonton Industrial Portfolio is a short drive to downtown Edmonton and the Edmonton International Airport. The Edmonton Industrial Portfolio is also in close proximity to the Trust’s existing Edmonton Industrial and Residential properties. The Edmonton Industrial Portfolio is 93% occupied and immediately...

Cohen & Company Reports Fourth Quarter & Full Year 2021 Financial Results

Written by Customer Service on March 8, 2022. Posted in Earnings Releases And Operating Results.

Board Declares Quarterly Dividend of $0.25 per Share and Special Dividend of $0.75 per Share Fourth Quarter Net Income Attributable to Cohen & Company Inc. of $3.6 Million, or $2.13 per Diluted Share Fourth Quarter Adjusted Pre-Tax Income of $6.4 Million, or $1.23 per Diluted Share Full Year Net Income Attributable to Cohen & Company Inc. of $11.3 Million, or $7.48 per Diluted Share Full Year Adjusted Pre-Tax Income of $32.8 Million, or $6.50 per Diluted Share PHILADELPHIA and NEW YORK, March 08, 2022 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN), a financial services firm specializing in fixed income markets and, more recently, in SPAC markets, today reported financial results for its fourth quarter and full year ended December 31, 2021. Summary Operating Results Three Months Ended Twelve...

InnerScope Hearing Technologies (OTC: INND) Announces Preliminary Revenue of $633,894 in the Fourth Quarter of 2021

Written by Customer Service on March 8, 2022. Posted in Earnings Releases And Operating Results.

InnerScope Experiencing Improved Sales Momentum from Acquisitions in the Fourth Quarter ROSEVILLE, Calif., March 08, 2022 (GLOBE NEWSWIRE) — via InvestorWire — InnerScope Hearing Technologies Inc. (OTC: INND) (“InnerScope”), an emerging and disruptive leader in the Direct-to-Consumer Hearing Technology space, today announced its preliminary unaudited revenue results of $633,894 for the fourth quarter (“Q4-2021”) ended December 31, 2021. Q4-2021 Business HighlightsAcquisitions of Direct-to-Consumer Hearing Aid Companies:Completed iHear Medical, San Leandro CA. (9-30-21) Completed HearingAssist, Virginia Beach, VA. (11-23-21)Acquisitions included:Manufacturing and R&D facility in San Leandro, CA. Management office in Virginia Beach, VA.Appointed Adnan Shennib as InnerScope’s...

Healthcare Triangle, Inc (HCTI) Reports Fourth Quarter and Full Year 2021 Results

Written by Customer Service on March 8, 2022. Posted in Earnings Releases And Operating Results.

PLEASANTON, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Healthcare Triangle, Inc (HCTI), a leading provider of Healthcare and Life Sciences cloud transformation, managed services and data analytics platform company today announced financial results for its fourth quarter and full year ended December 31, 2021. “We had a strong finish to the quarter,” said Suresh Venkatachari, Chairman and CEO of Healthcare Triangle. “I’m incredibly proud of the focus and dedication of our employees as we continue to innovate on our platforms and execute on our strategy.” “With our acquisition of Devcool Inc, we will expand our addressable market opportunities in the healthcare provider space, which will also offer our cloud and data analytics solutions on SaaS that drive better outcomes while lowering overall healthcare costs.” Fourth quarter 2021...

Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic

Written by Customer Service on March 8, 2022. Posted in Public Companies.

-Acre-scale seed production planned in spring 2022 -First winter PHA Camelina planting expected in fall 2022 -Research program to produce PHA co-polymers is underway WOBURN, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced recent advances in the development of Camelina as a platform for the production of PHA bioplastic directly in the seed. Field work completed during 2021 supports the Company’s decision to begin seed scale up of prototype PHA spring Camelina lines at acre-scale in 2022. Yield10 is also developing PHA winter Camelina lines and advancing its research program to increase the level and type of PHA production achievable in its Camelina plant varieties. “Camelina holds great promise as a platform crop for...

REMINDER/Stella-Jones Will Hold a Conference Call to Discuss Its Fourth Quarter 2021 Financial Results

Written by Customer Service on March 8, 2022. Posted in Public Companies.

MONTREAL, March 08, 2022 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX:SJ). OPEN TO: Investors, analysts, and all interested parties DATE: Wednesday, March 9, 2022 TIME: 10:00 a.m. EST CALL: 438-803-0545 (For all Montreal and overseas participants) 1-888-440-2194 (For all other North American participants)THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKETS OPEN THE DAY OF THE CONFERENCE CALL THROUGH GLOBENEWSWIRE. Please dial in 15 minutes before the conference begins. If you are unable to call in at this time, you may access a recording of the meeting by calling 1-800-770-2030 and entering the passcode 4899896 on your phone. This recording will be available on Wednesday, March 9, 2022 as of 1:30 p.m. until 11:59 p.m. on Wednesday, March 16, 2022. MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT...

Altra Industrial Motion Corp. to Host Investor Day Providing New Long-Term Strategy for Delivering Profitable Growth

Written by Customer Service on March 8, 2022. Posted in Public Companies.

Introduces 3-Year Financial Targets and Presents Path to $3B by 2027 Webcast to Begin Today at 10:00 a.m. ET BRAINTREE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Altra Industrial Motion Corp. (Nasdaq: AIMC) (“Altra” or the “Company”), a leading global manufacturer and supplier of motion control, power transmission and automation products, will host and webcast its 2022 Investor Day beginning at 10:00 a.m. ET today. During the event, presentations by Chief Executive Officer Carl Christenson, Chief Financial Officer Todd Patriacca, the company’s operating company presidents and other members of Altra’s senior leadership team will provide an in-depth review of the company’s foundational value drivers, review its new 3-pillar strategy for delivering sustainable profitable growth and introduce new three-year long-term financial targets. The...

SCYNEXIS Named to Fast Company’s 2022 Top 50 List of the World’s Most Innovative Companies

Written by Customer Service on March 8, 2022. Posted in Public Companies.

JERSEY CITY, N.J., March 08, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced it has been named to Fast Company’s annual list of the top 50 World’s Most Innovative Companies for 2022. “We are thrilled to be named by Fast Company to this year’s World’s Most Innovative Companies list,” said Marco Taglietti, M.D., President and Chief Executive Officer of SCYNEXIS. “The regulatory approval and launch of our revolutionary antifungal treatment for vaginal yeast infections was a tremendous accomplishment for us, and we are honored to receive this prestigious recognition.” The Fast Company magazine’s annual list of the country’s leading visionary companies provides a snapshot of significant...

Sarepta Therapeutics Announces Fifth Year of Route 79, The Duchenne Scholarship Program

Written by Customer Service on March 8, 2022. Posted in Public Companies.

Application website is now open for the 2022 Scholarship Program For the 2022-2023 academic year, the scholarship program has expanded to include two groups: one for individuals living with Duchenne and another for siblings in Duchenne families. CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the website for Route 79, The Duchenne Scholarship Program, is officially open and accepting applications. Academic scholarships of up to $5,000 will be awarded to up to 15 individuals living with Duchenne. Additionally, for the 2022-2023 school year, the program has been expanded and Sarepta will be awarding up to 5 academic scholarships of $5,000 to siblings of individuals living with Duchenne. The Route 79 program...

Radius Health Provides Business Update on Bone Health

Written by Customer Service on March 8, 2022. Posted in Public Companies.

Exclusive extension of research discovery collaboration with Mass General Hospital (MGH) Focus of the program: development of novel oral SIK inhibitors for musculoskeletal diseases Extension of activity is based on data from existing collaboration which generated nonclinical molecule data demonstrating oral activity of the skeletal anabolic TYMLOS® IP: additional patent issued that extends patent protection to January 10, 2040BOSTON, March 08, 2022 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) provided an update on business development and intellectual property progress in its Bone Health franchise. Massachusetts General Hospital Research Collaboration On December 15, 2020, Radius announced a discovery research collaboration with Massachusetts General Hospital (MGH) to evaluate novel oral...

Day: March 8, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals